title: Acidic fibroblast growth factor (FGF1) increases survival and haematopoietic recovery in total body irradiated C3H/HeNCr mice.
abstract: Basic fibroblast growth factor is known to stimulate the proliferation of bone marrow stem and/or progenitor cells in vitro and in vivo. We examined a similar cytokine, acidic fibroblast growth factor (FGF1), for its in vivo radiomodifying effects. Female C3H/HeNCr mice were given human recombinant FGF1 intravenously at doses ranging from 1 to 24 micrograms. FGF1 was delivered in two equal doses 24 and 4 h before or 24 h after otherwise lethal total body irradiation (TBI). In vivo FGF1 radioprotection of C3H mice was maximized at a total dose of 12 micrograms/mouse given before TBI. The radiomodification was 1.16 +/- 0.03 (+/- 1 SD) with an increase of LD50/30 from 736 +/- 9 to 854 +/- 16 cGy (P < 0.01). Some retroactive radiomodification was observed even when FGF1 was given 24 h after irradiation (P < 0.05). FGF1 radioprotected mice by improving the repopulation of haematopoietic progenitor cells of bone marrow. The radioprotection was not associated with an increase in S-phase fraction or detectable circulating IL-3, TNF-alpha or GM-CSF, suggesting that other mechanisms of protection were responsible.
authors.affiliation: Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
authors.forename: I
authors.initials: I
authors.lastname: Ding
authors.forename: T
authors.initials: T
authors.lastname: Wu
authors.forename: H
authors.initials: H
authors.lastname: Matsubara
authors.forename: J
authors.initials: J
authors.lastname: Magae
authors.forename: M
authors.initials: M
authors.lastname: Shou
authors.forename: J
authors.initials: J
authors.lastname: Cook
authors.forename: P
authors.initials: P
authors.lastname: Okunieff
mesh_terms: D000818:Animals; D001856:Bone Marrow Examination; D002453:Cell Cycle / Q000187:drug effects / Q000528:radiation effects; D004305:Dose-Response Relationship, Drug; D004353:Drug Evaluation, Preclinical; D005260:Female; D016220:Fibroblast Growth Factor 1 / Q000627:therapeutic use*; D006410:Hematopoiesis / Q000187:drug effects* / Q000528:radiation effects; D006801:Humans; D007928:Lethal Dose 50; D051379:Mice; D008809:Mice, Inbred C3H; D011837:Radiation-Protective Agents / Q000494:pharmacology*; D011994:Recombinant Proteins / Q000627:therapeutic use; D015996:Survival Rate; D014916:Whole-Body Irradiation
chemical_list: D011837:Radiation-Protective Agents; D011994:Recombinant Proteins; D016220:Fibroblast Growth Factor 1